Valuation: Becton, Dickinson and Company

Market Cap 43.08B 37.84B 35.19B 32.29B 60.67B 4,149B 61.61B 418B 163B 2,040B 162B 158B 7,053B P/E 2026 *
39x
P/E 2027 * 30.1x
Enterprise Value 59.6B 52.34B 48.68B 44.67B 83.93B 5,739B 85.22B 578B 226B 2,822B 224B 219B 9,756B EV / Sales 2026 *
3.1x
EV / Sales 2027 * 2.89x
Free-Float
74.04%
Yield 2026 *
2.46%
Yield 2027 * 2.5%
1 day+1.21%
1 week-1.87%
Current month+1.59%
1 month-0.08%
3 months+1.25%
6 months-24.01%
Current year-21.12%
1 week 150
Extreme 150
156.98
1 month 148.2
Extreme 148.2
162.95
Current year 139.58
Extreme 139.58
212.51
1 year 139.58
Extreme 139.58
212.51
3 years 139.58
Extreme 139.58
284.31
5 years 139.58
Extreme 139.58
286.33
10 years 139.58
Extreme 139.58
286.33
Manager TitleAgeSince
Chief Executive Officer 53 27/01/2020
Director of Finance/CFO 44 04/12/2025
Compliance Officer - 31/01/2023
Director TitleAgeSince
Director/Board Member 75 23/09/2002
Director/Board Member 71 25/07/2010
Chairman 53 27/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.21%-1.87% - - 43.08B
+2.29%+2.36%-18.56%-9.66% 180B
+1.46%+0.01%-10.47%-7.95% 107B
+1.58%+0.65%+6.73%+65.09% 60.29B
+0.67%-2.85%+26.76%+55.55% 50.19B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-19.61%-45.26% 27.61B
-7.67%-8.39%+24.55%-13.50% 23.1B
+1.63%-1.73%-7.11%-7.67% 20.86B
+3.90%+0.38%-13.17%-1.08% 19.5B
Average +0.46%-2.61%-1.36%+4.44% 57.82B
Weighted average by Cap. +0.30%-0.49%-6.31%+4.90%

Financials

2026 *2027 *
Net sales 19.21B 16.87B 15.69B 14.4B 27.06B 1,850B 27.47B 186B 72.81B 910B 72.13B 70.57B 3,145B 19.73B 17.32B 16.11B 14.78B 27.78B 1,900B 28.21B 191B 74.75B 934B 74.05B 72.45B 3,229B
Net income 1.12B 988M 919M 843M 1.58B 108B 1.61B 10.91B 4.26B 53.25B 4.22B 4.13B 184B 1.45B 1.27B 1.18B 1.09B 2.04B 140B 2.07B 14.06B 5.49B 68.61B 5.44B 5.32B 237B
Net Debt 16.51B 14.5B 13.49B 12.38B 23.26B 1,590B 23.62B 160B 62.58B 782B 61.99B 60.66B 2,703B 13.96B 12.26B 11.4B 10.46B 19.66B 1,344B 19.96B 135B 52.89B 661B 52.4B 51.27B 2,285B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
24/07/26 US$156.01 +2.28% 457
23/07/26 US$152.53 -0.14% 17
22/07/26 US$152.74 -0.37% 49
21/07/26 US$153.30 -1.99% 48
20/07/26 US$156.41 -0.54% 302
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
156.36USD
Average target price
179.36USD
Spread / Average Target
+14.71%

Quarterly revenue - Rate of surprise